These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29545472)

  • 21. Talk to Patients About: HPV.
    Price S
    Tex Med; 2018 Mar; 114(3):46. PubMed ID: 30625233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus, current vaccines, and cervical cancer prevention.
    Teitelman AM; Stringer M; Averbuch T; Witkoski A
    J Obstet Gynecol Neonatal Nurs; 2009; 38(1):69-80. PubMed ID: 19208050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae and human papillomavirus in a sexual health clinic setting in urban Sri Lanka.
    Samarawickrema NA; Tabrizi SN; Young E; Gunawardena P; Garland SM
    Int J STD AIDS; 2015 Sep; 26(10):733-9. PubMed ID: 25258396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The rationale for implementation of HPV testing in routine cervical screening in Romania.
    Iancu LS; Ursu RG
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
    [No Abstract]   [Full Text] [Related]  

  • 25. Chapter 19: Cost-effectiveness of cervical cancer screening.
    Goldie SJ; Kim JJ; Myers E
    Vaccine; 2006 Aug; 24 Suppl 3():S3/164-70. PubMed ID: 16950004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus infection (HPV) & screening strategies for cervical cancer.
    Sehgal A; Singh V
    Indian J Med Res; 2009 Sep; 130(3):234-40. PubMed ID: 19901432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of longterm hospital based cytological screening in asymptomatic women.
    Misra JS; Singh U
    Diagn Cytopathol; 2006 Mar; 34(3):184-7. PubMed ID: 16470854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical cancer screening in Switzerland: time to rethink the guidelines.
    Vassilakos P; Catarino R; Frey Tirri B; Petignat P
    Swiss Med Wkly; 2015; 145():w14112. PubMed ID: 25664576
    [No Abstract]   [Full Text] [Related]  

  • 30. [HPV vaccination and screening to eliminate cervical cancer. FIGO report].
    Ginekol Pol; 2008 Jun; 79(6):445-6. PubMed ID: 18652135
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current developments in uterine cervical carcinoma prevention and screening].
    Mathevet P; Jacot-Guillarmod M
    Rev Med Suisse; 2015 Oct; 11(492):1999-2003. PubMed ID: 26672178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
    Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
    Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the effectiveness of cervical cancer screening and prevention in Singapore.
    Chin FHX
    Ann Acad Med Singap; 2024 Jun; 53(6):338-339. PubMed ID: 38979988
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sex and prevention].
    Wielandt HB
    Ugeskr Laeger; 2009 Mar; 171(14):1157. PubMed ID: 19338731
    [No Abstract]   [Full Text] [Related]  

  • 37. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of HPV vaccination on future cervical screening: a simulation study of two birth cohorts in Denmark.
    Hestbech MS; Lynge E; Kragstrup J; Siersma V; Vazquez-Prada Baillet M; Brodersen J
    BMJ Open; 2015 Aug; 5(8):e007921. PubMed ID: 26275901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The current and future role of screening in the era of HPV vaccination.
    Myers E; Huh WK; Wright JD; Smith JS
    Gynecol Oncol; 2008 May; 109(2 Suppl):S31-9. PubMed ID: 18482556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The budget impact of cervical cancer screening using HPV primary screening.
    Wright T; Huang J; Baker E; Garfield S; Hertz D; Cox JT
    Am J Manag Care; 2016 Mar; 22(3):e95-105. PubMed ID: 26978241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.